800-401-4720
Recent Posts
Categories
Archives
Dangerous Drugs
Injuries
Contact Us
Dangerous Drugs and Injuiries Attorneys
Dangerous Drugs and Injuries Lawyers Who We Are What We Do Frequently Asked Questions Contact Us
We Sue Companies That Sell Dangerous Drugs
Nationwide Law Practice click here to be instantly connected to our office Medical and Legal News
« More Information on Association Between Anaplastic Large Cell Lymphoma (ALCL) and Breast Implants | Main  | Long-Term Fosamax Use More Than Doubles the Risk of Femur Fractures Among Older Women »
  Recall of Nexgen Complete Knee Solution Knee Replacement Components
Zimmer Inc. has initiated a Class 2 recall of the Nexgen Complete Knee Solution MIS tibial components, locking screw and stem extensions. The U.S. Food and Drug Administration issued a notice regarding the recall on September 13, 2010. The FDA Notice may be found HERE, which lists the specific codes for the recalled devices.

As of the date of the notice, there had been 114 reports filed with the FDA reporting that the device loosened, requiring patients to undergo surgery to replace the device. Immediately after the recall, Zimmer sent an “URGENT DEVICE CORRECTION” letter to orthopedic surgeons who had used the device. Zimmer warned surgeons to destroy or disregard all previous versions of the surgical technique and to review and familiarize themselves with the revised technique in light of the recall.

If you or a loved one underwent knee replacement surgery in which a Nexgen device was used, you ultimately may need to undergo surgery to replace the defective Nexgen device. Symptoms that may indicate a failure of the device include knee and joint pain, difficulty standing or walking, decreased range of motion, and soreness or stiffness.

Posted By DeCarli Law on February 11, 2011 05:33 pm | Permalink 

Comments

No Comments Posted
Attorney Web Design The information on this website is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship. DeCarli Law only represents individuals pursuant to a signed, written contract.

Address: 50 California Street, Suite 1500 San Francisco CA 94111 Toll Free: 1-800-401-4720 Phone: 1-415-738-6144
Debra DeCarli and Bob DeCarli are licensed by the State Bar of Texas and the State Bar of California.

DeCarli Law represents drug side effects and defective medical devices personal injury clients for claims, lawsuits and settlements in Alabama AL, Alaska AK, Arizona AZ, Arkansas AR, California CA, Colorado CO, Connecticut CT, Delaware DE, Georgia GA, Hawaii HI, Idaho ID, Illinois IL, Kansas KS, Maine ME, Maryland MD, Massachusetts MS, Minnesota MN, Mississippi MS, Montana MT, Nebraska NE, New Hampshire NH, New Jersey NJ, New Mexico NM, New York NY, North Carolina NC, North Dakota ND, Oklahoma OK, Oregon OR, Rhode Island RI, South Carolina SC, South Dakota SD, Tennessee TN, Utah UT, Vermont VT, Virginia VA, Washington WA, Washington D.C, West Virginia WV, Wisconsin WI and Wyoming WY. The attorneys of DeCarli Law are licensed in California and Texas. DeCarli Law's practice includes lawsuits for Propecia side effects, Finasteride lawsuits, Topamax lawsuits, Fosamax lawsuits, Gadolinium lawsuits, NSF lawsuits, Nephrogenic Systemic Fibrosis Lawsuits, YAZ lawsuits, Yasmin lawsuits, Ocella lawsuits, and Zarah lawsuits.